Society Logo
ME/CFS Australia Ltd
Please click here to donate ME/CFS South Australia Inc

Registered Charity 3104


Mailing address:

PO Box 322,
Modbury North,
South Australia 5092

1300 128 339

Office Hours:
Monday - Friday,
10am - 4pm

ME/CFS South Australia Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.


ME/CFS South Australia Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.

Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.

Become a Member
DOCX Application Form (Word, 198 KB)
Why become a member?

Scientists Develop Cannabis Pain Patches For Fibromyalgia

Friday 20 October 2017


From High Times:


Transdermal cannabis pain patch

Scientists Develop Cannabis Pain Patches for Fibromyalgia

By Tim Kohut
October 16, 2017
Copyright © 2017 High Times.

According to a press release from Cannabis Science, a firm that specializes in the creation of marijuana-based therapeutics, the company has developed two new cannabis-based medications for patients suffering from fibromyalgia and diabetic neuropathy nerve pain.

How They Work

The medications, which are essentially cannabis-based painkillers, will be dosed into the patient’s bloodstream through transdermal adhesive patches on the skin.

The transdermal method is considered ideal for patients because it can pinpoint exact dosages better than other traditional methods such as oral, topical, intravenous and intramuscular. It also facilitates treating a particular part of the body that is afflicted by the disorders, as opposed to the whole body.


Full article…


Arrow right

More Fibromyalgia News



blog comments powered by Disqus
Previous Previous Page